Company: PRGO
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0001585364-25-000014
Chunk: 253

Company: PERRIGO Co plc
Filing Date: 2025-02-28
Form: 10-K
Item: Item 8
Chunk 253
---
 balance$2.3 $1.6 $27.9 $1.0 $32.8  Year EndedDecember 31, 2023Supply Chain ReinventionHRA Pharma Integration Project EnergizeOther InitiativesTotalBeginning balance$2.2 $13.3 $— $4.3 $19.8 Additional charges28.0 4.2 7.4 2.6 42.2 Payments(13.4)(10.9)(4.5)(4.6)(33.4)Non-cash adjustments(16.1)0.2 — (0.5)(16.4)Ending balance$0.7 $6.8 $2.9 $1.8 $12.2 Year EndedDecember 31, 2022Supply Chain ReinventionOther InitiativesTotalBeginning balance$— $6.9 $6.9 Additional charges24.3 18.2 42.5 Payments(22.1)(7.7)(29.8)Non-cash adjustments— 0.2 0.2 Ending balance$2.2 $17.6 $19.8 

105

Perrigo Company plc - Item 8Note 17

The charges incurred during the year ended December 31, 2024 were primarily associated with actions taken on Project Energize activities associated with employee separation, consulting fees and lease exit costs. The charges incurred during the year ended December 31, 2023 were primarily associated with actions taken on our multi-year supply chain restructuring, including an asset impairment of $16.1 million, Project Energize and HRA integration activities. The charges incurred during the year ended December 31, 2022 were primarily associated with actions taken on supply chain restructuring and HRA integration activities.Of the amount recorded during the year ended December 31, 2024, $53.8 million was related to our CSCI segment and $28.9 million related to our CSCA segment, and $27.4 million was related to our Unallocated segment. For all segments, amounts were due primarily to Project Energize. Of the amount recorded during the year ended December 31, 2023, $21.4 million was related to our CSCI segment, due primarily to supply chain restructuring and HRA Pharma integration initiatives and $13.0 million was related to